ResMed | RMD - أصول متداولة





أصول متداولة تغيير تاريخ
Ansell USD 1.11B 5.2M 2025-12
Artivion USD 338.81M 32.57M 2026-09
AtriCure USD 363.39M 17.86M 2026-09
Baxter International USD 6.83B 163M 2026-09
Cochlear AUD 1.37B 43.9M 2025-12
Cooper Companies USD 2.28B 18.3M 2026-06
CSL USD 11.85B 1000K 2025-12
Dexcom USD 3.92B 170.6M 2026-09
Edwards Lifesciences USD 7.25B 428.6M 2026-09
Fisher Paykel Healthcare NZD 1.15B 168.5M 2026-06
Globus Medical USD 2.18B 33.55M 2026-09
Haemonetics USD 855.53M 44.7M 2026-09
Idexx Laboratories USD 1.5B 9.48M 2026-09
Inogen USD 203.72M 594K 2025-09
Insulet USD 2.04B 192.4M 2026-09
Integra LifeSciences USD 1.19B 1.54M 2026-09
Intuitive Surgical USD 10.65B 1.68B 2026-09
Medtronic USD 24.39B 397M 2026-06
Philips EUR 10.51B 1.18B 2026-09
Ramsay Health Care AUD 3.56B 480.3M 2025-12
ResMed USD 3.51B 815.82M 2026-09
Sigma Healthcare AUD 2.91B 2B 2025-12
Sonic Healthcare AUD 2.3B 52.76M 2024-12
Steris USD 2.48B 33.4M 2026-09
Teleflex USD 1.84B 31.2M 2026-09
Thermo Fisher Scientific USD 25.62B 2.25B 2026-09